Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Photobiomodulation Effects on Blood Pressure and Vascular Function in Treated Hypertensive Patients

NCT: NCT07525310 · RECRUITING

NCT IDNCT07525310
StatusRECRUITING
Start Date2026-09-01
Completion2027-11-30
SponsorUniversity of Nove de Julho (OTHER)
First posted
Last updated

Brief Summary

This double-blind, randomized, sham-controlled clinical trial aims to evaluate the effects of vascular photobiomodulation on blood pressure and vascular function in hypertensive patients treated with losartan. A total of 80 patients using losartan (100 mg/day for at least two months) will be recruited and followed for 4 weeks. Participants will be randomly allocated to either an active photobiomodulation group or a sham control group.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑